Acutaas Chemicals Ltd

Acutaas Chemicals Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Buy to Hold as of 30 July 2026. This adjustment reflects a nuanced assessment across four key parameters: Quality, Valuation, Financial Trend, and Technicals. Despite strong long-term growth and robust institutional backing, recent quarterly performance and technical indicators have tempered enthusiasm, prompting a more cautious stance among investors.

Acutaas Chemicals Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a subtle shift in its technical momentum, reflected in a downgrade of its Mojo Grade from Buy to Hold as of 30 July 2026. Despite a strong year-to-date return of 89.9%, recent price action and technical indicators suggest a cautious stance for investors amid mixed signals from key momentum and trend metrics.

Acutaas Chemicals Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 24 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 27 July 2026, providing investors with the most up-to-date insight into the company’s performance and outlook.

Acutaas Chemicals Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has reported a mixed set of quarterly results for June 2026, reflecting a shift from an outstanding to a positive financial trend. While the company’s half-year performance demonstrates robust growth in profitability and sales, recent quarterly figures reveal some contraction in earnings, signalling a nuanced outlook for investors.

Acutaas Chemicals Ltd., a mid-sized pharmaceutical chemicals manufacturer, reported consolidated net profit of ₹74.26 crores for Q1 FY27, reflecting a sharp 43.64% quarter-on-quarter decline from ₹131.76 crores in Q4 FY26, though maintaining a respectable 67.67% year-on-year growth. The company's shares tumbled 5.75% to ₹3,257.15 following the results announcement, as investors reacted to significant margin compression and sequential profit contraction despite robust topline expansion.

Acutaas Chemicals Ltd is rated 'Strong Buy' by MarketsMOJO, with this rating last updated on 28 January 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 16 July 2026, providing investors with the latest insights into its performance and outlook.

Surging to a new 52-week high of Rs 3,735 on 6 Jul 2026, Acutaas Chemicals Ltd has demonstrated remarkable price momentum, outperforming the broader market with a 225.35% gain over the past year against the Sensex’s decline of 6.35%. This milestone caps a sustained rally driven by a confluence of robust technical indicators and strong underlying fundamentals.

Acutaas Chemicals Ltd is rated 'Strong Buy' by MarketsMOJO, with this rating last updated on 28 January 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 05 July 2026, providing investors with the latest insights into its performance and outlook.

Surging to a new 52-week and all-time high of Rs 3,724.05 on 3 Jul 2026, Acutaas Chemicals Ltd has demonstrated remarkable price momentum, outperforming the broader market and its sector peers with a 235.76% return over the past year.

With a remarkable surge to Rs 3675 on 2 Jul 2026, Acutaas Chemicals Ltd has reached a new 52-week and all-time high, reflecting a sustained rally that has more than tripled its share price from the 52-week low of Rs 1085.75. This milestone is underpinned by a confluence of strong technical indicators and robust price momentum that have propelled the stock well above its key moving averages.

Acutaas Chemicals Ltd has reached a significant milestone by touching its all-time high price of Rs. 3,675 on 02 Jul 2026, reflecting a strong performance trajectory in the Pharmaceuticals & Biotechnology sector.

Surging past its previous peaks, Acutaas Chemicals Ltd touched a new 52-week high of Rs 3606.5 on 01 Jul 2026, marking a remarkable 216.62% gain over the past year. This milestone comes amid a backdrop of strong technical momentum and sustained earnings growth, setting the stage for a compelling price rally.

Acutaas Chemicals Ltd has reached a significant milestone by touching an all-time high price of Rs. 3,606.5 on 01 Jul 2026, reflecting its robust performance in the Pharmaceuticals & Biotechnology sector and underscoring its strong market momentum.

While the Sensex declined by 0.49% on 29 Jun 2026, Acutaas Chemicals Ltd surged 8.78%, reaching a new 52-week and all-time high of Rs 3600.5. This 8.62 percentage-point outperformance over its Pharmaceuticals & Biotechnology sector peers highlights a distinctly stock-specific rally in an otherwise weak market environment.

Surging past its previous peaks, Acutaas Chemicals Ltd reached a fresh 52-week high of Rs 3472.55 on 29 Jun 2026, marking a remarkable 208.45% gain over the past year. This milestone reflects a powerful confluence of technical momentum and sustained earnings growth that has propelled the stock well ahead of the broader market.

Acutaas Chemicals Ltd has reached a significant milestone by touching its all-time high price on 29 June 2026, reflecting a remarkable trajectory of growth and robust financial performance within the Pharmaceuticals & Biotechnology sector.

Acutaas Chemicals Ltd is rated Strong Buy by MarketsMOJO, with this rating last updated on 28 January 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 24 June 2026, providing investors with the latest insights into its performance and outlook.